GC1107
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GC1107, covering 2015-01-26 to 2015-02-12. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults [Phase 3]